TY - JOUR
T1 - Neuromotor control associates with muscle weakness observed with McArdle sign of multiple sclerosis
AU - Schilaty, Nathan D.
AU - Savoldi, Filippo
AU - Nasr, Zahra
AU - Weinshenker, Brian G.
N1 - Funding Information:
The authors acknowledge the support of NIH grants K12HD065987 and L30AR070273, the Mayo Clinic Center for Multiple Sclerosis and Autoimmune Neurology, and the University of South Florida Center for Neuromusculoskeletal Research. Funding Information
Funding Information:
The authors acknowledge the support of NIH grants K12HD065987 and L30AR070273, the Mayo Clinic Center for Multiple Sclerosis and Autoimmune Neurology, and the University of South Florida Center for Neuromusculoskeletal Research.
Publisher Copyright:
© 2022 The Authors. Annals of Clinical and Translational Neurology published by Wiley Periodicals LLC on behalf of American Neurological Association.
PY - 2022/4
Y1 - 2022/4
N2 - Objective: Multiple Sclerosis (MS) is often accompanied by myelopathy, which may be associated with progressive worsening. A specific finding of MS-associated myelopathy is McArdle sign, wherein neck flexion is associated with prominent increased limb weakness relative to that detected with neck extension. In this study, we characterized neuromotor control properties of finger extensors in association with the McArdle sign. Methods: A custom-built device was utilized to monitor torque production of the wrist extensors with simultaneous recording of surface electromyography of the extensor digitorum. The electromyography was decomposed and analyzed via both linear and nominal regressions. Results: Linear regressions demonstrated a strong difference between groups for MS from healthy controls and other myelopathies for motor unit action potential amplitude and average firing rate (p < 0.001). Further, linear regression demonstrated good correlations of neuromotor variables to mechanical torque output (0.24 ≤ R2 ≤ 0.76). Nominal regression distinguished MS from healthy controls with an AUC of 0.87, specificity of 0.97, and sensitivity of 0.64. Nominal regression of MS from other myelopathies demonstrated an AUC of 0.88, specificity of 0.85, and sensitivity of 0.79. Interpretation: These data demonstrate the neuromotor control factors that largely determine muscle force production change with the observation of McArdle sign; these neuromotor control factors can differentiate MS from both healthy controls and other myelopathy conditions.
AB - Objective: Multiple Sclerosis (MS) is often accompanied by myelopathy, which may be associated with progressive worsening. A specific finding of MS-associated myelopathy is McArdle sign, wherein neck flexion is associated with prominent increased limb weakness relative to that detected with neck extension. In this study, we characterized neuromotor control properties of finger extensors in association with the McArdle sign. Methods: A custom-built device was utilized to monitor torque production of the wrist extensors with simultaneous recording of surface electromyography of the extensor digitorum. The electromyography was decomposed and analyzed via both linear and nominal regressions. Results: Linear regressions demonstrated a strong difference between groups for MS from healthy controls and other myelopathies for motor unit action potential amplitude and average firing rate (p < 0.001). Further, linear regression demonstrated good correlations of neuromotor variables to mechanical torque output (0.24 ≤ R2 ≤ 0.76). Nominal regression distinguished MS from healthy controls with an AUC of 0.87, specificity of 0.97, and sensitivity of 0.64. Nominal regression of MS from other myelopathies demonstrated an AUC of 0.88, specificity of 0.85, and sensitivity of 0.79. Interpretation: These data demonstrate the neuromotor control factors that largely determine muscle force production change with the observation of McArdle sign; these neuromotor control factors can differentiate MS from both healthy controls and other myelopathy conditions.
UR - http://www.scopus.com/inward/record.url?scp=85126204331&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85126204331&partnerID=8YFLogxK
U2 - 10.1002/acn3.51526
DO - 10.1002/acn3.51526
M3 - Article
C2 - 35289110
AN - SCOPUS:85126204331
SN - 2328-9503
VL - 9
SP - 515
EP - 528
JO - Annals of Clinical and Translational Neurology
JF - Annals of Clinical and Translational Neurology
IS - 4
ER -